Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 2001, p. 4309-4315, Vol. 39, No. 12
Research Center for Pathogenic Fungi and
Microbial Toxicoses, Chiba University, Chiba, Japan
Received 26 February 2001/Returned for modification 11 July
2001/Accepted 11 September 2001
The genetic diversity of recent clinical isolates of Candida
albicans in Japan was studied on the basis of amplified DNA
band lengths determined with a specific PCR primer reported to have been designed to span a transposable intron region in the 25S rRNA
gene. Our analyses of 301 clinical isolates of C.
albicans showed that they could be classified into five
genotypes: genotype A (172 isolates), genotype B (66 isolates),
genotype C (56 isolates), genotype D (C. dubliniensis; 5 isolates), and a new genotype (designated genotype E; 2 isolates). The
new genotype E was characterized to have a group I intron-like
sequence, which is longer than hitherto reported ones and which has a
nucleotide sequence length of 962 bp. Our analysis of the 962-bp
sequence indicated that it is composed of an intron similar to that of
C. dubliniensis of 621 bp with a 341-bp insertion.
Analysis of the sequence of the internal transcribed spacer
(ITS) region of the genotype E strain showed that its sequence is identical to those of strains of other genotypes, with only a few
base substitution differences. Throughout the study, the possible
horizontal transfer of the group I intron between C. dubliniensis and C. albicans was suggested. A
high degree of correlation between the presence of a group I intron in
C. albicans genotype E and susceptibility to the
antifungal agent flucytosine was observed. The five isolates of
C. dubliniensis examined in the present study showed
genetic diversity when they were compared by randomly amplified polymorphic DNA fingerprinting pattern analysis, and this diversity was
also confirmed by the analysis of ITS region sequences.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4309-4315.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Molecular Characterization of New Clinical Isolates of
Candida albicans and C. dubliniensis in
Japan: Analysis Reveals a New Genotype of C.
albicans with Group I Intron
*
Corresponding author. Mailing address: Research Center
for Pathogenic Fungi and Microbial Toxicoses, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba (260-8673), Japan. Phone: 81-43-226-2493. Fax:
81-43-226-2486. E-mail:
mikami{at}myco.pf.chiba-u.ac.jp.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»